- Tytuł:
- Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia: A Canadian healthcare payer perspective.
- Autorzy:
- Źródło:
- Canadian Urological Association Journal. Apr2023, Vol. 17 Issue 4, p103-110. 8p.
Czasopismo naukowe